Singapore markets closed
Straits Times Index
3,260.03 -11.54 (-0.35%) S&P 500
4,349.93 -6.52 (-0.15%) Dow
34,168.09 -129.61 (-0.38%) Nasdaq
13,542.12 +2.82 (+0.02%) BTC-USD
36,876.11 -1,484.73 (-3.87%) CMC Crypto 200
843.42 -12.40 (-1.45%)
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:02PM EST
Pre-market:
| Previous close | 123.27 |
| Open | 119.19 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 119.00 - 121.68 |
| 52-week range | 105.36 - 142.60 |
| Volume | |
| Avg. volume | 5,948,162 |
| Market cap | 217.976B |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | 29.79 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.88 (1.53%) |
| Ex-dividend date | 13 Jan 2022 |
| 1y target est | N/A |
- CNW Group
Abbott Receives Health Canada Authorization Under Interim Order to Expand Use of FreeStyle® Libre System for Pregnant Women in the Hospital and Professional Health Care Settings
In April 2020, Abbott received authorization from Health Canada to allow the FreeStyle Libre system to be used by frontline health care workers to remotely monitor the glucose status and glucose history of their patients without the need for painful finger pricks.1 This minimized exposure to COVID-19 and preserved the use of personal protective equipment (PPE) while enabling healthcare providers to make important treatment decisions, as needed.
© 2022 Yahoo. All rights reserved.
